Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
- PMID: 10617473
- DOI: 10.1126/science.286.5449.2528
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
Abstract
The hCHK2 gene encodes the human homolog of the yeast Cds1 and Rad53 G2 checkpoint kinases, whose activation in response to DNA damage prevents cellular entry into mitosis. Here, it is shown that heterozygous germ line mutations in hCHK2 occur in Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in the TP53 gene. These observations suggest that hCHK2 is a tumor suppressor gene conferring predisposition to sarcoma, breast cancer, and brain tumors, and they also provide a link between the central role of p53 inactivation in human cancer and the well-defined G2 checkpoint in yeast.
Comment in
-
Checkpoint gene linked to human cancer.Science. 1999 Dec 24;286(5449):2433-4. doi: 10.1126/science.286.5449.2433a. Science. 1999. PMID: 10636795 No abstract available.
Similar articles
-
Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.J Med Genet. 2001 Apr;38(4):253-7. doi: 10.1136/jmg.38.4.253. J Med Genet. 2001. PMID: 11370630 Free PMC article. No abstract available.
-
Checkpoint gene linked to human cancer.Science. 1999 Dec 24;286(5449):2433-4. doi: 10.1126/science.286.5449.2433a. Science. 1999. PMID: 10636795 No abstract available.
-
Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.Surg Oncol Clin N Am. 2009 Jan;18(1):145-56, ix. doi: 10.1016/j.soc.2008.08.006. Surg Oncol Clin N Am. 2009. PMID: 19056046 Review.
-
DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.Cancer Res. 1997 May 15;57(10):1895-902. Cancer Res. 1997. PMID: 9157982
-
TP53, hChk2, and the Li-Fraumeni syndrome.Methods Mol Biol. 2003;222:117-29. doi: 10.1385/1-59259-328-3:117. Methods Mol Biol. 2003. PMID: 12710683 Review.
Cited by
-
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.Am J Hum Genet. 2003 May;72(5):1308-14. doi: 10.1086/375121. Epub 2003 Apr 10. Am J Hum Genet. 2003. PMID: 12690581 Free PMC article.
-
The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study.Med Arch. 2023 Feb;77(1):8-12. doi: 10.5455/medarh.2023.77.8-12. Med Arch. 2023. PMID: 36919124 Free PMC article.
-
Xenopus Cds1 is regulated by DNA-dependent protein kinase and ATR during the cell cycle checkpoint response to double-stranded DNA ends.Mol Cell Biol. 2004 Nov;24(22):9968-85. doi: 10.1128/MCB.24.22.9968-9985.2004. Mol Cell Biol. 2004. PMID: 15509799 Free PMC article.
-
Collaboration of Brca1 and Chk2 in tumorigenesis.Genes Dev. 2004 May 15;18(10):1144-53. doi: 10.1101/gad.1192704. Epub 2004 May 6. Genes Dev. 2004. PMID: 15131084 Free PMC article.
-
Guidelines for the management of soft tissue sarcomas.Sarcoma. 2010;2010:506182. doi: 10.1155/2010/506182. Epub 2010 May 31. Sarcoma. 2010. PMID: 20634933 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous